Similar to CD23, as further discussed below, CD21 downregulation identifies expanded fractions in several diseases characterized by increased B cell autoreactivity including SLE, CVID, Sjogren's syndrome, and RA (12, 41, 85, 104–107). This evidence concerns the gene FCER2 and systemic lupus erythematosus.